학술논문
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Document Type
Article
Author
Chan, S.L.; Schuler, M.; Kang, Y.-K.; Yen, C.-J.; Edeline, J.; Choo, S.P.; Lin, C.-C.; Okusaka, T.; Weiss, K.-H.; Macarulla, T.; Cattan, S.; Blanc, J.-F.; Lee, K.-H.; Maur, M.; Pant, S.; Kudo, M.; Assenat, E.; Zhu, A.X.; Yau, T.; Lim, H.Y.; Bruix, J.; Geier, A.; Guillén-Ponce, C.; Fasolo, A.; Finn, R.S.; Fan, J.; Vogel, A.; Qin, S.; Riester, M.; Gu, Y.; Katsanou, V.; Porta, D.G.; Chaudhari, M.; Kakizume, T.; Myers, A.; Delord, J.-P.
Source
In: Journal of Experimental and Clinical Cancer Research . (Journal of Experimental and Clinical Cancer Research, December 2022, 41(1))
Subject
Language
English
ISSN
17569966